|
Faculty members have disclosed the following information on affiliations
and significant relationships with commercial companies, and disclosure
of unlabeled use and investigational product discussion.
| Faculty Member |
Commercial Co. |
Relationship |
Product Discussion Unlabeled/Investig. |
| D. Craig Allred, M.D. |
AstraZeneca |
Consultant & speaker bureau |
|
| Werner P. Audretsch, M.D. |
None |
|
|
|
Patrick I. Borgen, M.D.
Mary B. Daly, M.D.
|
None
AstraZeneca
Lilly
|
Clinical grants
STAR trial
|
|
| Bruno D. Fornage, M.D. |
Rita Medical Systems |
Clinical grants |
|
| Darius Francescatti, M.D. |
Cytyc Health Corporation |
Consulting |
|
| Steven E. Harms, M.D. |
Aurora Imaging |
Consultant & stock |
RODEO |
| Daniel F. Hayes, M.D. |
AstraZeneca, Aventis,
Bristol Myers-Squibb, Novartis,Wyeth |
Consultant/advisory panel/lecturer |
|
| I. Craig Henderson, M.D. |
OrthoBiotech |
Consulting & financial interest |
|
| Anthony Howell, M.D. |
AstraZeneca, Pharmacia |
Consulting |
Anastrozole & Letrozole |
| Cliff Hudis, M.D. |
AstraZeneca, Aventis, Genentech,
Bristol Myers-Squibb, OrthoBiotech,
Eli Lilly, Pharmacia, Upjohn, Roche |
Consulting |
VEGF antibody |
| Stephen E. Jones, M.D. |
AstraZeneca, Roche, Pharmacia, Aventis |
Speakers Bureau |
|
| Susan M. Love, M.D. |
Cytyc Health Corporation,
Sanarus Medical, Inc |
Financial interest |
|
| Eleftherios P. Mamounas, M.D. |
Aventis, Pharmacia, Bristol Myers-Sqibb,
AstraZeneca, Roche, Eli Lilly |
Consulting |
Docetaxel, Celecoxib,
Capecitabine |
| Prof. Robert Mansel |
None |
|
|
| Richard G. Margolese M.D. |
None |
|
|
| Kathy Miller, M.D. |
Eli Lilly |
Consulting |
Multiple investigational agents |
| C. Kent Osborne, M.D. |
AstraZeneca, Aventis, Genentech, Bristol Myers-Squibb,
OrthoBiotech, Eli Lilly, Pharmacia, Upjohn, Roche |
Consulting |
Iressa, EGFR Inhibitor |
| Joyce O’Shaughnessy M.D. |
Cytyc Health Corporation |
Consulting |
|
| Emanuel Petricoin, M.D. |
None |
|
Herceptin, Gleevec, Iressa |
| Peter M. Ravdin, M.D. |
Adjuvant, Inc. |
Consulting & financial |
|
| Prof. John FR Robertson |
AstraZeneca, Bristol Myers |
Lectures & advisor y |
Tumor Markers, endocrine agents |
| Freya Schnabel, M.D. |
None |
|
|
| Gordon F. Schwartz, M.D. |
None |
|
|
| Rache Simmons, M.D. |
RITA Medical |
Clinical grants |
RITA, Radiofrequency ablation |
| S. Eva Singletary, M.D. |
Cytyc Health Corporation |
Medical Advisory Committee |
|
| Debu Tripathy, M.D. |
AstraZeneca, Lilly |
Clinical grant funding, consulting |
|
| Frank A. Vicini, M.D. |
None |
|
|
| Prof. Umberto Veronesi |
None |
|
|
| Victor G. Vogel, M.D. |
straZeneca, Eli Lilly, Pharmacia & Cytyc Health
Corporation |
Speaker’s Bureau |
|
| Tim Whelan, M.D. |
None |
|
|
Back | Top of Page
|
|
